Intel is leading chip gains. A top analyst sees the stock hitting $200 in two years

Melius Research reiterated a buy on Intel with a $165 price target, implying roughly 70% upside, and said the stock could reach $200 within two years if Intel's 14A foundry process secures high-volume commitments from Apple, Tesla and another hyperscaler. The bullish thesis also assumes sustained server CPU pricing, agentic-AI CPU demand and a higher AI-PC mix supporting product earnings above $4 per share by 2028. Reuters separately reported Intel is considering leasing part of its Ohio fab to SK Hynix for U.S. memory-chip production; Intel shares rose more than 4%, extending a roughly 300% gain over the past year.

Analysis

The valuation debate is no longer primarily about Intel Products earnings; it is about whether Intel Foundry can convert prospective customer discussions into bankable utilization. A major external tenant would improve Ohio fixed-cost absorption and lend credibility to the broader foundry model, but a lease or manufacturing-services arrangement is economically inferior to a long-duration, take-or-pay leading-edge wafer commitment. The market should distinguish between facility monetization and proof that 14A can win high-margin, high-volume logic workloads.

The key second-order risk is capital intensity. Even successful customer announcements can be equity-negative if they require Intel to pre-fund tooling and capacity before customer prepayments, depressing free cash flow and extending the balance-sheet repair timeline. Conversely, credible customer-funded capacity, wafer prepayments, or government support would reduce the execution discount more than a headline partnership alone; this is the metric most likely to drive multiple expansion over the next 1-3 months.

After a sharp rerating, the asymmetry is less attractive for outright momentum exposure: the bull case embeds simultaneous product-margin recovery, sustained pricing discipline, and foundry execution. AAPL and TSLA should not receive meaningful read-through until there is a disclosed node, volume, qualification timeline, and commercial structure; both retain substantial alternative manufacturing options. Over 6-18 months, successful domestic memory/packaging activity could also support equipment and materials demand, but it does not establish Intel's competitiveness in frontier logic.

Contrarian view: low published buy ratings may look like latent upgrade fuel, but they also reflect legitimate uncertainty around yield, customer qualification, and returns on invested capital. The next earnings report needs to show improving gross-margin trajectory and foundry loss containment, not merely strategic interest, for the upside case to remain credible.

Key Decisions for Investors

• Do not chase INTC on partnership speculation. Establish a 1-3 month watch trigger for disclosed external 14A volume commitment with customer prepayment or take-or-pay terms; absent those terms, treat any initial rally as vulnerable to reversal.
• For existing INTC longs, trim into a further 10-15% headline-driven move and retain upside through a 6-12 month call spread rather than unhedged common exposure. Thesis is falsified by a gross-margin guide-down, higher capex without offsetting customer funding, or delayed 14A qualification.
• Prefer a catalyst pair trade only after earnings confirmation: long INTC / short SOXX in equal beta-adjusted dollars if Intel shows sequential margin improvement and funded foundry backlog. This isolates company-specific execution upside from broad AI-semiconductor multiple risk; exit if foundry losses widen or product ASPs soften.
• Monitor SK Hynix (000660 KS) and U.S. memory-capex suppliers for confirmation of any Ohio arrangement, but do not infer material earnings impact until wafer volumes, process ownership, and economics are disclosed. A conventional facility lease is more relevant to Intel utilization than to SK Hynix margin expansion.